by admin | Feb 14, 2024 | News & Opinions
By Kyle LaHucik – Endpoints News Neurona Therapeutics has gathered $120 million in what is expected to be its last private financing round to wrap up an open-label study this year and move its epilepsy cell therapy into a randomized Phase II in 2025, CEO and...
by admin | Feb 13, 2024 | News & Opinions
by Marni Ellery – Berkley Engineering – Nobel laureate details new applications at Kuh Distinguished Lecture. Jennifer Doudna, Nobel laureate and Li Ka Shing Chancellor’s Chair and Professor in the Departments of Chemistry and of Molecular and Cell...
by admin | Feb 12, 2024 | News & Opinions
By Edvard Pettersson – Courthouse News Service – The FDA asked the Ninth Circuit to follow their colleagues on the 11th Circuit and find that novel stem cell procedures are not exempt from the agency’s oversight. PASADENA, Calif. (CN) — The U.S. Food...
by admin | Feb 6, 2024 | News & Opinions
By Dr. Gracelyn Santos – SILive.com Binghamton sophomore and Staten Islander, Hayley Bond, 19, recently traveled to Grand Rapids, Michigan, to donate her stem cells, after being informed she was a match for a leukemia patient, in desperate need of a bone marrow...
by admin | Feb 5, 2024 | News & Opinions
By Penn Medicine News – Penn Today – The development of any type of second cancer following CAR T cell therapy is a rare occurrence, as found in an analysis of more than 400 patients treated at Penn Medicine, researchers from the Perelman School of...
